Bramlage P, Lanzinger S, van Mark G, et al. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases. Cardiovasc Diabetol. 2019;18(1):33.

International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium, International Diabetes Federation (2019) https://www.diabetesatlas.org/en/, Accessed 23rd July 2022

Owolabi MO, Yaria JO, Daivadanam M, et al. COUNCIL Initiative. Gaps in guidelines for the management of diabetes in low- and middle-income versus high-income countries: Systematic review. Diabetes Care. 2018;41(5):1097-105.

Usman MS, Khan MS, Butler J. The interplay between diabetes, cardiovascular disease, and kidney disease. Chronic kidney disease and type 2 diabetes. Arlington (VA): American Diabetes Association; 2021 Jun.

American Diabetes Association. Glycemic targets: Standards of medical care in diabetes—2021. Diabetes Care. 2021;44 (Suppl.1): S73–S84.

Aminde LN, Tindong M, Ngwasiri CA, et al. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocr Disord. 2019;19(1):35.

Matthews D, Del Prato S, Mohan V, et al. Insights from verify: Early combination therapy provides better glycaemic durability than a stepwise approach in newly diagnosed type 2 diabetes. Diabetes Ther. 2020;11(11):2465-76.

Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C, et al. Update on the treatment of type 2 diabetes mellitus. World J Diabetes. 2016;7(17):354-95.

Foma MA, Saidu Y, Omoleke SA, et al. Awareness of diabetes mellitus among diabetic patients in the Gambia: a strong case for health education and promotion. BMC Public Health. 2013;13:1124.

Ji L, Bonnet F, Charbonnel B, Gomes MB, et al. Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program. J Diabetes Complications. 2017;31(7):1188-96.

Gomes MB, Rathmann W, Charbonnel B, et al; DISCOVER investigators. Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study. Diabetes Res Clin Pract. 2019;151:20-32. doi: 10.1016/j.diabres.2019.03.024.

Putri PM, Murdi PB. Pelayanan kesehatan di era jaminan kesehatan nasional sebagai program badan penyelenggara jaminan sosial kesehatan. Jurnal Wacana Hukum. 2019;25(80):10-33061.

Hidayat B, Ramadani RV, Rudijanto A, et al. Direct medical cost of type 2 diabetes mellitus and its associated complications in Indonesia. Value Health Reg Issues. 2022;28:82-9.

Cholil AR, Lindarto D, Pemayun TGD, et al. DiabCare Asia 2012: diabetes management, control, and complications in patients with type 2 diabetes in Indonesia. Med J Indones. 2019;28(1):47-56.

(PERKENI) PEI. Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 dewasa di Indonesia: PB PERKENI; 2019.

Shi L, Shu XO, Li H, et al. Physical activity, smoking, and alcohol consumption in association with the incidence of type 2 diabetes among middle-aged and elderly Chinese men. PLoS One. 2013;8(11):e77919.

Ramachandran A, Jain SM, Mukherjee S, et al. Suboptimal glycemic control among subjects with diabetes mellitus in India: a subset analysis of cross-sectional wave-7 (2016) data from the International Diabetes Management Practices Study (IDMPS). Ther Adv Endocrinol Metab. 2020;11:2042018820937217.

Soeatmadji DW, Rosandi R, Saraswati MR, et al. Clinicodemographic profile and outcomes of type 2 diabetes mellitus in the Indonesian cohort of DISCOVER: A 3-year prospective cohort study. J ASEAN Fed Endocr Soc. 2023;1-7.

Paul SK, Klein K, Thorsted BL, et al. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:100.

Soewondo P, Ferrario A, Tahapary DL. Challenges in diabetes management in Indonesia: a literature review. Global Health. 2013;9:63.